Drug delivery specialist Gerresheimer boosts 3rd-quarter revenue; MonoSol grabs Canadian patent tied to drug film tech;

> Drug delivery specialist Gerresheimer said that its third-quarter revenue rose 9.9% to €285.1 million. Report

> Montreal-based Theratechnologies ($THER) said that it has found a new growth-hormone releasing factor peptide (GRF) that could be used in treatments for more medical conditions than its existing GRF. Release

> British drug giant AstraZeneca ($AZ) plans to pump $200 million into a new factory in China to produce injectable and oral drugs. Report

> MonoSol Rx has been granted a Canadian patent related to its drug-delivery film products, two of which have recently gained FDA approval. Item

> Depomed, a developer of extended-release drugs, said that its Gralise tablets for once-daily treatment of pain after shingles are now available. Announcement